Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Positron announced it has placed orders for its sales of five Attrius(TM) PET scanners.

Positron Corporation , a leading molecular imaging company specializing in the field of nuclear cardiology, announced it has placed orders for its sales of five Attrius(TM) PET scanners. The sales of these systems are for leading cardiology practices and hospitals. The Company also reported that with these orders, it expects to meet the high-end of its previously announced 2010 growth targets.

The Company noted that these current orders of five Attrius(TM) PET scanners are in addition to the ones previously announced in June and early September. With today's announcement, the Company fully anticipates it will reach the high-end of its previously stated sales goal of approximately 12 to 15 Attrius(TM) PET systems in 2010, equating to approximately $10 million to $12 million in sales, part of which will be recognized in the first quarter of 2011.

"We are pleased to report the orders of these additional systems, as well as the sales previously announced, as they serve as further evidence that mainstream cardiologists are embracing PET. The Attrius(TM) provides an elegant solution to managing coronary disease cost effectively; Positron is well-positioned to meet the rising demand and establish itself as a clear leader in cardiac PET ," said Patrick G. Rooney, chief executive officer of Positron .

Source: Positron Corporation

Click on the link to see more PET Scanners